To analyze this hypothesis, we investigated expression of IL10, CD274, and PDCD1LG2 and the two miRNAs significant after correction for multiple testing, miR-1 and miR-625 (Table 3), in whole blood in pregnant and untreated MS patients. This evidence concerns the gene IL10 and myeloid sarcoma.